BSE •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 12:32
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization706,191 mln
Float802 mln
Earnings Date08/06/2026
EPS
2.82
Stretched
P / E
153
Highly speculative
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.32
Borderline
1-Year Forecast
424
Fairly priced
Relative Strength
51
/ 100
In line with market
Business Description
Founded in 1978 and based in Bengaluru, India, Biocon Limited is a biotechnology company that develops and sells a broad range of medicines, including treatments for diabetes, cancer, heart disease, and autoimmune conditions. The company operates across India, the United States, Ireland, and other global markets through its generics, biosimilars, and research divisions. Biocon also partners with pharmaceutical and healthcare companies worldwide to support drug discovery, clinical research, and manufacturing.
